These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17690349)

  • 1. Court dismisses Novartis challenge to Indian patent law.
    Mudur G
    BMJ; 2007 Aug; 335(7614):273. PubMed ID: 17690349
    [No Abstract]   [Full Text] [Related]  

  • 2. Novartis challenges India's drug patent laws in Supreme Court.
    Billingsley M
    BMJ; 2012 Feb; 344():e1279. PubMed ID: 22354594
    [No Abstract]   [Full Text] [Related]  

  • 3. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 4. Supreme Court of India rejects Novartis’ cancer drug patent.
    Heseltine P
    Pharm Pat Anal; 2013 May; 2(3):299-300. PubMed ID: 24237056
    [No Abstract]   [Full Text] [Related]  

  • 5. [Novartis should discontinue its patent case in India!].
    PehrOlov P
    Lakartidningen; 2007 Feb 14-20; 104(7):524. PubMed ID: 17375688
    [No Abstract]   [Full Text] [Related]  

  • 6. Indian Supreme Court rejects Novartis's appeal on drug patent.
    Arie S
    BMJ; 2013 Apr; 346():f2099. PubMed ID: 23550079
    [No Abstract]   [Full Text] [Related]  

  • 7. Patent watch: Indian Supreme Court blocks Novartis’ Glivec patent.
    Harrison C
    Nat Rev Drug Discov; 2013 May; 12(5):336-7. PubMed ID: 23598506
    [No Abstract]   [Full Text] [Related]  

  • 8. Novartis faces growing pressure to drop patent case against Indian government.
    Hargreaves S
    BMJ; 2007 Feb; 334(7590):383. PubMed ID: 17322224
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes to India's patent law may deny cheap drugs to millions.
    Mudur G
    BMJ; 2005 Mar; 330(7493):692. PubMed ID: 15790640
    [No Abstract]   [Full Text] [Related]  

  • 10. MSF challenges Novartis's action over Indian patent for imatinib.
    Mudur G
    BMJ; 2007 Jan; 334(7586):172. PubMed ID: 17255582
    [No Abstract]   [Full Text] [Related]  

  • 11. How do public health safeguards in Indian patent law affect pharmaceutical patenting in practice?
    Sampat BN; Amin T
    J Health Polit Policy Law; 2013 Aug; 38(4):735-55. PubMed ID: 23645877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legal challenge to India's patent laws threatens access to generic drugs, says charity.
    Moszynski P
    BMJ; 2011 Sep; 343():d5753. PubMed ID: 21908529
    [No Abstract]   [Full Text] [Related]  

  • 13. "To patent or not to patent? the case of Novartis' cancer drug Glivec in India".
    Gabble R; Kohler JC
    Global Health; 2014 Jan; 10():3. PubMed ID: 24393270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered in India--patent law 2.0.
    Kapczynski A
    N Engl J Med; 2013 Aug; 369(6):497-9. PubMed ID: 23862973
    [No Abstract]   [Full Text] [Related]  

  • 15. The challenge to patent law of pure chemical protein synthesis.
    Fellmeth AX
    Nat Biotechnol; 2005 May; 23(5):547-9. PubMed ID: 15877067
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug patent. Court rejects Glaxo's motion to dismiss AZT patent lawsuit.
    AIDS Policy Law; 2003 Aug; 18(15):7. PubMed ID: 14974388
    [No Abstract]   [Full Text] [Related]  

  • 17. India: Court upholds patent law denying patents for slightly modified versions of existing drugs.
    Swamy M
    HIV AIDS Policy Law Rev; 2007 Dec; 12(2-3):50-1. PubMed ID: 18459215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. India: multi-national pharmaceutical company challenges patent law.
    Betteridge G
    HIV AIDS Policy Law Rev; 2007 May; 12(1):35, 38. PubMed ID: 17715534
    [No Abstract]   [Full Text] [Related]  

  • 19. Court orders development of evidence before ruling on patent.
    AIDS Policy Law; 2003 Jun; 18(11):7. PubMed ID: 12866470
    [No Abstract]   [Full Text] [Related]  

  • 20. [The Glivec® case: the first example of a global debate on the drug patent system].
    Moital I; Bosch F; Farré M; Maddaleno M; Baños JE
    Gac Sanit; 2014; 28(6):470-4. PubMed ID: 25110309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.